OMER Stock Analysis: Buy, Sell, or Hold?

OMER - Omeros Corporation

PHARMACEUTICAL PREPARATIONS
$9.81
-0.07 (-0.71%) ▼
5d: -7.97%
30d: -18.59%
90d: -37.56%
HOLD
MODERATE Confidence
Protect Your OMER Gains
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: Mar 31, 2026 TODAY
Smart Money Accumulation

OMER is down 6.5% this week, but smart money is accumulating calls. Top strike: $11 2026-05-15 with 1,820 OI. Call ratio: 84% View Scanner →

Strength: 6.7/10

Get Alerted When OMER Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: OMER shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$17.05
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$10.59
7.3% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: OMER is currently trading at $9.81, which is considered oversold relative to its 30-day fair value range of $10.61 to $11.86. From a valuation perspective, the stock is trading at a discount (Forward PE: 20.2) compared to its historical average (114.4). Remarkably, the market is currently pricing in an annual earnings decline of 43.9% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, OMER is in a strong uptrend. The price is currently testing key support at $9.77. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: OMER has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $38.00 (+287.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD
Fair Price Range $10.61 - $11.86
Company Quality Score 58/100 (HOLD)
Options IV Signal 36th percentile (NORMAL)
Volume Confirmation HIGH
Confidence Score 59.6%

Protect Your Profits

Holding OMER? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Options fairly priced (IV 36th percentile)
  • BEARISH: Weak technical setup (25/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 287.4% below Wall St target ($38.00)
  • CAUTION: 5-day price weakness (-8.0%) - monitor closely

Fair Price Analysis

30-Day Fair Range $10.61 - $11.86
Current vs Fair Value OVERSOLD
Expected Move (7 Days) ±$1.32 (13.5%)

Support & Resistance Levels

Support Level $9.77
Resistance Level $11.44
Current Trend Strong Uptrend
Technical data as of Mar 30, 2026

Fundamental Context

Forward P/E (Next Year Est.) 20.16
Wall Street Target $38.00 (+287.4%)
Revenue Growth (YoY) 14.9%
Valuation Discount vs History -43.9% cheaper
PE vs Historical 20.2 vs 114.4 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -43.9% (market-implied from PE analysis)
1-Year Target $8.83 (-10%)
2-Year Target $7.95 (-19%)
3-Year Target $7.15 (-27%)
3-Yr Target (if PE normalizes) (PE: 20→114) $40.59 (+314%)
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 20.2 to 114.4
Stabilization Target: $55.68 (+467.6%)
PE Expansion Potential: +467.6%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: March 30, 2026 6:35 PM ET
Data refreshes hourly during market hours. Next update: 7:35 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
David J Borges SELL 30000 shares 2026-01-13

Unlock Insider Activity

See real-time buying/selling by company executives for OMER.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
AXSM
Axsome Therapeutics Inc
STRONG BUY
19 analysts
$222 59 HOLD
RARE
Ultragenyx
STRONG BUY
20 analysts
$54 53 HOLD
INCY
Incyte Corporation
HOLD
27 analysts
$108 61 BUY
CRNX
Crinetics Pharmaceutical…
STRONG BUY
17 analysts
$84 58 HOLD
MDGL
Madrigal Pharmaceuticals…
STRONG BUY
15 analysts
$669 67 BUY

Advanced OMER Option Strategies

Professional options setups generated by AI based on today's OMER price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for OMER

OMER Technical Chart OMER Price Prediction OMER Earnings Date OMER Investment Advisor OMER Fair Price Analyzer OMER Options Advisor OMER Options Chain OMER Options Analysis OMER Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals